파이프라인
| Therapeutic Area | Code | Indication | Discovery | CMC | Preclinical Trial |
Clinical Trial | ||
|---|---|---|---|---|---|---|---|---|
| Phase Ⅰ | Phase Ⅱ | Phase Ⅲ | ||||||
| Neurodegen. Disease | HSN001E0 | Alzheimer Disease |
|
|||||
| Skin Disease | HSN002E0 | Atopic Dermatitis |
|
|||||
| Skin Disease | HSN002E1 | Atopic Dermatitis |
|
|||||
| Skin Disease | HSN002C0 | Atopic Dermatitis |
|
|||||
| Cancer | HSN002C1 | Colon/Breast Cancer |
|
|||||
| Skin Disease | HSN003C0 | Psoriasis |
|
|||||
| Virus | HSN004C0 | Influenza, HIV |
|
|||||
| Cancer | HSN005C0 | Colon/Breast Cancer |
|
|||||
| Virus | HSN006C0 | Influenza |
|
|||||
| Cancer | HSN007C0 | Colon/Breast Cancer |
|
|||||
| Cancer | HSN008C0 | Colon/Breast Cancer |
|
|||||
| Autoimmune | HSN009C0 | T1DM, Rheumatis |
|
|||||
| Retinopathy | HSN010C0 | P21 over expression |
|
|||||
| Antifungal | HSN011C0 | Fungicidal |
|
|||||
| Antispasm | HSN012B0 | BoNT |
|
|||||